On May 21, 2025 Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported two upcoming investor events (Press release, Arcellx, MAY 21, 2025, View Source [SID1234653282]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen’s 6th Annual Oncology Innovation Summit
Tuesday, May 27, 2025 at 9:00 a.m. PT (Virtual)

Management and Physician Presentation and Discussion of iMMagine-1 Pivotal Study Results During EHA (Free EHA Whitepaper)2025
Friday, June 13, 2025 at 8:30 p.m. CEST (Virtual and In-Person, Milan, Italy)

A live webcast of these discussions will be accessible from Arcellx’s website at www.arcellx.com in the Investors section. A replay of the webcasts will be archived and available for 30 days following the event.